EIR Changzhou Pharmaceutical Factory Apr 2009

Paul Bellamy FDA$595.00 - Available Now

FDA investigators audited the Changzhou Pharmaceutical Factory - Changzhou, China facility and issued inspectional observation (via FDA 483) on 02 Apr 2009.

Product details

  • Category:
  • Inspection end: 02 Apr 2009
  • Location: Changzhou, China
  • FEI: 3002806661
Add To Cart